Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 8 hours agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE -0.07%) stock was a hot buy...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 6 hours agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 6 hours agoAll 16 voting members of the panel recommended that FDA ask companies target the JN.1 variant or a...
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth | Investing.com UK
Investing.com· 2 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 1 day agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 6 hours agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
Pfizer Is Getting Healthier and There's a Key Level for Buyers to Watch
TheStreet.com· 22 hours agoIn the updated daily bar chart of PFE, below, I can see this is the second test of the 200-day...